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Library Synthesis in Flow
Continuous Flow Synthesis of Urea-Containing Compound
Libraries Based on the Piperidin-4-one Scaffold
Alejandra Riesco-Domínguez,[a] Daniel Blanco-Ania,[a] and Floris P. J. T. Rutjes*[a]
Abstract: The advantages of performing reactions in continu-
ous flow vs. the classic batch processes render flow chemistry
a suitable technique for library synthesis. Inspired by our recent
work to create fluorine-containing nitrogen heterocycles and
Introduction
The urea group represents an important functionality in phar-
maceutical and agrochemical products.[1] Urea-containing mol-
ecules possess an immense potential in drug design as a result
of their capability for hydrogen binding to biomolecular tar-
gets.[2] Moreover, ureas are widely used in drug design for the
modulation of several factors, such as selectivity, stability, toxic-
ity and pharmacokinetic profile of lead molecules.[2] Examples
of active compounds containing a urea unit are depicted in
Figure 1. Trimefluor,[3] a selective pre- and post-emergence her-
bicide for use in cotton, and triflumuron,[4] a broad spectrum
insecticide against chewing insects commercialized by Bayer
CropScience, are examples of bioactive molecules containing a
urea group. Another example of a urea-containing pharmaceu-
tical is vestipitant,[5] a selective antagonist for the NK1 receptor.
Figure 1. Biologically active compounds containing a urea group.
Recently, we reported an enantio- and diastereoselective
synthesis of piperidin-4-ones 2a–c from the enantiopure amino
ketone 1 (Scheme 1).[6] Compounds 2a–c, containing three dif-
ferent fluorine functionalities (F, CF3 and SF5) to enhance their
bioactivity and metabolic profile,[7] were synthesized and fur-
ther derivatized into a novel library of spirocyclic compounds
[a] Institute for Molecules and Materials, Radboud University,
Heyendaalseweg 135, 6525 AJ Nijmegen, the Netherlands
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by the potential of the urea group in drug design, we herewith
describe the combination of both aspects in the continuous
flow synthesis of two libraries of urea derivatives based on the
piperidin-4-one scaffold.
(3 and 4) under classic batch processes through a diastereo-
selective Pictet–Spengler cyclization.[6]
Scheme 1. Previously reported work (batch) and this work (flow) based on
scaffolds 2a–c.
The inherent potential of this scaffold (2a–c) for derivatiza-
tion combined with the advantages of flow chemistry for library
synthesis[8] (including excellent heat exchange and fast mixing
for better reaction control, automated small-scale optimization
and rapid automated compound-library preparation) encour-
aged us to further develop a new class of urea derivatives in
flow (5 and 6) based on scaffolds 2a–c (Scheme 1).
Results and Discussion
We started our investigations by testing the reactivity of our
amines (2b and 2c) with alkyl isocyanates (ethyl [7A] or iso-
propyl isocyanate [7B], 1.5 equiv.) varying solvent, temperature
and reaction time (see Table 1 for summarized results and Sup-
porting Information [SI] for the entire optimization process). All
reactions were carried out in a borosilicate glass reactor (chan-
nel width 600 μm, channel depth 500 μm and effective reactor
volume 100 μL).[9] The microreactor was placed into a micro-
reactor holder, which automatically aligns with the fluidic con-
nections and makes contact with the temperature controlled
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metal plate in the microreactor holder. Then, the inlet modules
were connected through the microreactor holder with the inlet
ports of the microreactor and the outlet tubing was also placed
at the outlet port. The tubing was connected to the syringes,
which were connected to the pumps. The two solutions, one
containing the piperidin-4-ones (2b or 2c) and the other one
with the isocyanates 7 were pumped and brought together in-
side of the microreactor (Table 1). Initially, we used solvents
such as MeCN or 1,2-dichloroethane in a temperature range of
50–80 °C and reaction times of 10–15 minutes (entries 1–4).
Low conversions to ureas 5bA and 5bB were obtained in all
these cases and only a slightly higher conversion to 5bA (ratio
5bA/2b 1:0.7) was achieved when we used MeCN at 50 °C (en-
try 1). The use of EtOH at 80 °C and a reaction time of 10
minutes provided a ratio of 1:1.2 for 5bB/2b (entry 5). An in-
crease of the reaction time to 15 minutes (entry 6) gave higher
conversion into product 5bB (1:0.15). By increasing the amount
of isocyanate (2.0 and 2.5 equiv., entries 7 and 8, respectively),
nearly full conversion to 5bB and full conversion to 5cA were
obtained. However, carbamate 8 was also formed in the reac-
tion mixture when EtOH was used as solvent, as a result of the
nucleophilic attack of EtOH to the isocyanate. Therefore, we
explored the use of bulkier alcohols as solvent (iPrOH and
tBuOH) to avoid the formation of 8. Thus, the reaction of piper-
idin-4-one 2c with ethyl isocyanate (2.5 equiv.) in the presence
of propan-2-ol gave full conversion to urea 5cA and less forma-
tion of the carbamate 8 (entry 9) whereas the formation of 8
was completely suppressed when tert-butyl alcohol was used
(entry 10).[10] With this result in hands, we tried to decrease the
temperature of the reaction and the amount of isocyanate
used. We confirmed that when using 2.0 equiv. of ethyl isocyan-
Table 1. Optimization process for the synthesis of alkyl and aryl ureas 5b and 5c.
Entry Substrate 7 [equiv.] Solvent t [°C] time Product 8 R R1 Ratio 5/2/8[a] Flow rate
[min] [μL/min]
1 2b 7A (1.5) MeCN 50 10 5bA – CH3CH2 – 1:0.7:0[b] 10.00
2 2b 7A (1.5) MeCN 80 10 5bA – CH3CH2 – 1:10:0 10.00
3 2b 7A (1.5) MeCN 80 15 5bA – CH3CH2 – 1:5.0:0 6.67
4 2b 7B (1.5) 1,2-DCE 80 15 5bB – (CH3)2CH – 1:6.0:0 6.67
5 2b 7B (1.5) EtOH 80 10 5bB 8a (CH3)2CH CH3CH2 1:1.2:0.14 10.0
6 2b 7B (1.5) EtOH 80 15 5bB 8a (CH3)2CH CH3CH2 1:0.15:0.31 6.67
7 2b 7B (2.0) EtOH 80 17 5bB 8a (CH3)2CH CH3CH2 1:0.08:0.31 5.88
8 2c 7A (2.5) EtOH 80 17 5cA 8b CH3CH2 CH3CH2 1:0:0.92 5.88
9 2c 7A (2.5) iPrOH 80 17 5cA 8c CH3CH2 (CH3)2CH 1:0:0.6 5.88
10 2c 7A (2.5) tBuOH 80 17 5cA – CH3CH2 – 1:0:0[10] 5.88
11 2c 7A (2.0) tBuOH 25 17 5cA – CH3CH2 – 1:0.12:0[11] 5.88
12 2c 7A (2.0) tBuOH 35 17 5cA – CH3CH2 – 1:0.10:0[11] 5.88
13 2c 7A (2.0) tBuOH 50 17 5cA – CH3CH2 – 1:0:0[11] 5.88
14 2b 7E (1.5) EtOH 80 20 5bE 8d 2,4-F2C6H3 CH3CH2 0:1:0.50 5.00
15 2b 7E (1.3) 1,2-DCE 80 17 5bE – 2,4-F2C6H3 – 1:0:0 5.88
[a] Calculated by 1H NMR of the fraction of the collected product. [b] Analyzed by 1H NMR of the fraction of stabilization time.
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ate and temperatures between 25–35 °C full conversion was
not reached (entries 11 and 12). Finally, we found that the use
of 2.0 equiv. of ethyl isocyanate at 50 °C in tBuOH were the
suitable conditions to obtain full conversion to compound 5cA
(entry 13). Once the conditions for the synthesis of aliphatic
ureas were optimized, we attempted the synthesis of the aryl
derivatives. Therefore, we first explored the reaction of 2b with
2,4-difluorophenyl isocyanate (7E, 1.5 equiv.) at 80 °C in EtOH
and a reaction time of 20 minutes; the reaction, however, did
not show any conversion to product 5bE and it resulted in a
mixture of 2b and carbamate 8 (ratio 2b/8d 1:0.50; entry 14).
By changing the solvent to 1,2-dichloroethane, and using
1.3 equiv. of isocyanate 7E, full conversion to compound 5bE
was obtained (entry 15).
With the final conditions in hands, five isocyanates 7A–E
(alkyl and aryl isocyanates with different substituents on the
phenyl ring, Figure 2) were selected for the generation of a 15-
compound library (Table 2). For all experiments, three fractions
(stabilization time, collected product and residual) were col-
lected in separated vials and final products were analyzed di-
Figure 2. Isocyanates used for the generation of the library.
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Table 2. Library of ureas 5aA–cE based on the piperidin-4-one scaffold.
[a] Reaction carried out in tBuOH at 50 °C in 17 minutes using 2.0 equiv. of isocyanate. [b] Reaction carried out in 1,2-dicloroethane at 80 °C in 17 min using
1.3 equiv. of isocyanate. [c] Conversion calculated by 1H NMR of the fraction of collected product. [d] Isolated yield of the fraction of collected product.
rectly by 1H NMR from the fraction of collected product. This
fraction always started after running three cycles of the stabili-
zation time (see [SI] for experimental details).[12]
The reaction of piperidin-4-ones 2a–c with alkyl isocyanates
7A and 7B gave full conversions to products 5aA–cB in very
good to excellent yields (83–92 %).
We also obtained full conversions to ureas 5aC–cE when aryl
isocyanates (7C–E) were used. Very good to excellent yields
were obtained for compounds 5aC, 5aE, 5bC and 5cC–cE. Good
yields were obtained for compounds 5aD and 5bD whereas
compound 5bE was obtained with a moderate yield. The excess
of isocyanates was removed in vacuo as much as possible so
that only small amounts of the least volatile isocyanates re-
mained in the reaction mixtures. The crude mixtures of com-
pounds 5bA and 5bB showed the presence of a minor product
in a 1:0.1 ratio according to their 1H NMR spectra. We attributed
these mixtures to be either rotamers of the urea group or a
possible mixture of atropisomers, with the carbamoyl group (al-
most) perpendicular to the piperidine ring (Figure 3), both
caused by the congested 2,6-diphenylpiperidine-1-carbox-
amide framework. For ureas 5bC and 5bD, the ratio of the iso-
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mers could not be measured accurately whereas for the rest of
ureas only one of both isomers was observed.
Figure 3. Rotamers and atropisomers of 5bA and 5bB.
Optimization of these reactions to obtain full conversion was
crucial because no further column chromatography was re-
quired. Purifying these poorly soluble ureas generally requires
polar solvents such as MeOH, but in case of sterically congested
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ureas methanolysis[13] may take place in the purification proc-
ess. In this case, methanolysis occurred because the nitrogen in
the piperidine ring might not be fully conjugated anymore with
the carbonyl and therefore MeOH can form a hydrogen bond
with the nitrogen. To analyze the reactivity of these ureas in
MeOH, we dissolved urea 5aC in CD3OD and monitored the
mixture by 1H NMR (Scheme 2). We observed that compound
5aC was still present after 1–4 h, but after 19 h at room temper-
ature compound 5aC transformed into piperidin-4-one 2a (pro-
tonated and deuterated substrates), phenyl isocyanate 7C and
carbamates 9 and 10 (relative abundance 9/10 30:70). 1H NMR
showed a mixture of compounds which was confirmed by
GC–MS (Scheme 2).
Scheme 2. Methanolysis of ureas 5aC and 5cB.
We also studied the decomposition of the aliphatic urea 5cB,
which also showed the presence of carbamates 9 and 10 (de-
tected by GC–MS) and the starting material 2c (protonated and
deuterated substrates).
Finally, a diastereoselective reduction of ketone 2c was car-
ried out in flow using LiBH4 as reducing reagent to provide full
conversion to a 10:1 mixture of piperidinols 11 and 12
(Scheme 3). The workup of this reaction was performed offline
after the reaction mixture was completely collected in the cor-
responding vial. The reduction of ketone 2b was performed in
batch using N-Selectride[14] to give alcohol 12.[15]
Scheme 3. Reduction of 2a and 2c with N-Selectride and LiBH4.
Then, we decided to perform the urea synthesis using as
starting material amino alcohol 11 (Table 3). Initially, we per-
formed the reaction between 11 and isocyanate 7B using the
conditions previously developed for aliphatic isocyanates
(tBuOH, 17 min and 50 °C). We decreased the amount of 7B to
1.0 equiv., to firstly test the reactivity of our hindered amine in
the presence of the nucleophilic alcohol. We confirmed by 1H
NMR that only the amine group reacted with the isocyanate
and therefore the corresponding carbamate was not observed.
However, while using 1.0 equiv. of isocyanate, a ratio 11/6b
1:0.5 was obtained. Thus, we increased the amount of isocyan-
ate 7B to 1.5 equiv. and full conversion to urea 6b was achieved
(84 % yield). When we applied these conditions using ethyl (7A)
and benzyl (7F) isocyanates, amino alcohol 11 was converted
with full conversion to ureas 6a and 6c[16] in 85 and 99 % yield,
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respectively. Finally, two additional examples with aryl isocyan-
ates (7C and 7D) were synthesized. In this case, the use of
1.1 equiv. of isocyanate in 1,2-DCE at 80 °C was sufficient to
reach full conversion to ureas 6d and 6e. For compounds 6a–
e, a 6:1 ratio of conformers was obtained.
Table 3. Library of ureas 6a–e based on amino alcohol 11.
[a] Reaction carried out in tBuOH at 50 °C in 17 min using 1.5 equiv. of
isocyanate. [b] Reaction carried out in 1,2-dicloroethane at 80 °C in 17 min
using 1.1 equiv. of isocyanate. [c] Conversion calculated by 1H NMR of the
fraction of collected product. [d] Isolated yield of the fraction of collected
product.
As previously mentioned, the presence of the conformers
(rotamers or atropisomers) was caused by the hindered rotation
around one of the single N–CO bonds of the urea.[17] NOESY
experiments of compound 13a (the major product of reaction
between alcohol 12 and isocyanate 7B) showed correlations
between the NH of the urea with both benzylic protons
(Table 4), indicating therefore the existence of atropisomerism
(in case of rotamers, each rotamer would show only one corre-
Table 4. Chemical shifts [ppm] of atropisomers 13a and 13b in CDCl3.
Entry 1H [ppm] (13a) [ppm] (13b)
1 H2 4.89 4.36
2 H3 2.11/1.84 2.20–2.10/2.00–1.89
3 H4 4.43 4.16
4 H5 2.70/2.00 2.37/2.20–2.10
5 H6 5.65 5.12
6 H7 3.80–3.70 3.58–3.49
7 H8 0.88 0.72
8 H9 0.74 0.60
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lation with one benzylic proton).[18] The assignment of the char-
acteristic protons is depicted in Table 4. Chemical shifts of com-
pounds 13a and 13b[19] present a considerable difference, not
only for the benzylic protons H2 and H6 (entries 1 and 5), but
also for protons H4 and H7 (entries 3 and 6). We were also able
to confirm that the major product of the stereoisomers was
compound 13a, which showed a correlation between the NH
proton of the urea and both benzylic protons, H2 and H6. The
clarification of these two products was done by NOESY studies.
Conclusions
In summary, we have synthesized a small library of ureas in
continuous flow. The reactions utilized for their syntheses were
achieved in a reaction time of 17 min without further need of
purification rendering drug-like molecules. Moreover, we have
also diastereoselectively reduced the ketone group in flow in
3 min reaction time. Additional urea formation of amino alcohol
11 was also performed to create five different urea derivatives.
NMR studies confirmed the formation of conformers caused by
the hindered rotation around one of the single N–CO bonds of
the urea. The elucidation of these species to be identified as
either rotamers or atropisomers could not be clarified. This
methodology could be applied to a wide range of substrates as
a tool to prepare libraries of potentially bioactive molecules.
Experimental Section
General Information: Reagents were obtained from commercial
suppliers and were used without purification. Standard syringe
techniques were applied for the transfer of dry solvents and air- or
moisture-sensitive reagents. Reactions were followed by 1H NMR,
and RF values were obtained, using thin layer chromatography (TLC)
on silica gel-coated plates (Merck 60 F254) with the indicated sol-
vent mixture. Detection was performed with UV light, and/or by
charring at ca. 150 °C after dipping into a solution of KMnO4.
Infrared spectra were recorded on an IR-ATR Bruker TENSOR 27
spectrometer. High-resolution or accurate mass measurement
(ΔM < 3mmu or 5 ppm) were recorded on a JEOL AccuTOF-CS JMS-
T100CS for Electrospray (spectra recorded in infusion in MeOH con-
taining 50 nM PPG-475 as internal mass-drift compensation stan-
dard) or JEOL AccuTOF-GCv JMS-T100GCv (GC/Electron Ionization
MS, column bleeding at high temperature used as internal mass
drift compensation standard) for methanolysis experiments. NMR
spectra were recorded at 298 K on a Varian Inova 400 (400 MHz),
Bruker Avance III 400 MHz or Bruker Avance III 500 MHz spectrome-
ter in the solvent indicated. Chemical shifts are given in parts per
million (ppm) with respect to tetramethylsilane (δ =0.00 ppm) as
internal standard for 1H NMR; and CDCl3 (δ =77.16 ppm) as internal
standard for 13C NMR spectroscopy. Coupling constants are re-
ported as J values in Hertz [Hz]. 1H NMR spectroscopic data are
reported as follows: chemical shift (ppm), multiplicity (s = singlet,
d = doublet, dd = doublet of doublets, dt = doublet of triplets,
dq = doublet of quartets, ddd = doublet of doublet of doublets,
quint = quintet, t = triplet, td = triplet of doublets, m = multiplet),
coupling constants [Hz], and integration. Compounds were fully
characterized by 1H, 13C, COSY, HSQC, HMBC and NOESY. Reactions
were carried out using the FlowStart Evo equipment and microreac-
tors purchased by FutureChemistry (futurechemistry.com accessed
Sep 11, 2017). At very low flow rates, stabilization and pressure
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of the equipment may take long; therefore, a stabilization time is
calculated and run before the collecting product fraction. The stabi-
lization time is calculated following Equation (1):[12]
Stabilization Time = 3 × Reactor Volume/Total Flow Rate (1)
For all reactions, products were analyzed from the collected fraction
and therefore calculations and yields and based on this fraction.
General Procedure for the Synthesis of Alkyl Ureas 5aA, 5aB,
5bA, 5bB, 5cA and 5cB: Solution A: piperidin-4-one (2a–c,
1.0 equiv.) dissolved in tBuOH (99.8–100.2 mM). Solution B: alkyl
isocyanate (7A or 7B, 2.0 equiv.) dissolved in tBuOH (0.1 M). Solution
A (1.96 μL/min) was combined with B (3.92 μL/min) inside the glass
microreactor (internal volume: 100 μL). The reaction was performed
at 50 °C for 17 min.
(2S,6R)-2-(3,4-Dimethoxyphenyl)-N-ethyl-6-(4-fluorophenyl)-4-
oxopiperidine-1-carboxamide (5aA): According to the general
procedure, the react ion of piper id in-4-one 2a (3 .63 mg,
0.011 mmol) in tBuOH (99.8 mM) with 7A afforded urea 5aA
(3.67 mg, 9.16 μmol). 1H NMR (400 MHz, CDCl3): δ = 7.39–7.31 (m,
2 H), 7.08–7.01 (m, 2 H), 6.80 (d, J = 8.2 Hz, 1 H), 6.75 (dd, J = 8.2,
2.1 Hz, 1 H), 6.64 (d, J = 2.1 Hz, 1 H), 6.00 (t, J = 5.4 Hz, 1 H), 5.22
(dd, J = 9.7, 4.9 Hz, 1 H), 4.40 (t, J = 5.2 Hz, 1 H), 3.86 (s, 3 H), 3.73
(s, 3 H), 3.18–3.07 (m, 3 H), 2.88–2.73 (m, 2 H), 2.60 (dd, J = 17.6,
4.9 Hz, 1 H), 0.88 (t, J = 7.2 Hz, 3 H) ppm. 13C NMR (101 MHz, CDCl3):
δ = 207.8, 162.1 (d, J = 247.5 Hz), 159.1, 150.1, 149.0, 139.0 (d, J =
3.1 Hz), 134.9, 128.4 (d, J = 8.0 Hz), 117.9, 116.0 (d, J = 21.5 Hz),
111.4, 108.9, 56.1, 56.0, 52.4, 46.1, 43.6, 36.2, 15.2 ppm. FTIR: ν˜ =
3420, 2967, 1722, 1639, 1511, 1264, 1228, 1025 cm–1. HRMS [ESI
(m/z)] calcd. for (C22H25FN2O4 + Na)+ = 423.16906, found 423.16916
(|Δ| = 1.0 ppm). RF: 0.27 (heptane/AcOEt, 1:2). Yield: 83 %.
(2S,6R)-2-(3,4-Dimethoxyphenyl)-N-ethyl-4-oxo-6-[4-(trifluoro-
methyl)phenyl]piperidine-1-carboxamide (5bA): According to
the general procedure, the reaction of piperidin-4-one 2b (4.68 mg,
0.012 mmol) in tBuOH (100.2 mM) with 7A afforded urea 5bA
(4.74 mg, 0.011 mmol). 1H NMR (400 MHz, CDCl3): δ = 7.66–7.60 (m,
2 H), 7.56–7.51 (m, 2 H), 6.80 (d, J = 8.2 Hz, 1 H), 6.75 (ddd, J = 8.2,
2.1, 0.5 Hz, 1 H), 6.54 (d, J = 2.1 Hz, 1 H), 6.20 (t, J = 5.2 Hz, 1 H),
5.12 (dd, J = 10.2, 4.9 Hz, 1 H), 4.44 (t, J = 5.2 Hz, 1 H), 3.86 (s, 3 H),
3.67 (s, 3 H), 3.23–3.11 (m, 3 H), 2.86 (dd, J = 18.4, 5.6 Hz, 1 H), 2.74
(dd, J = 17.5, 10.2 Hz, 1 H), 2.61 (dd, J = 17.5, 4.9 Hz, 1 H), 0.90 (t,
J = 7.2 Hz, 3 H) ppm. 13C NMR (101 MHz, CDCl3): δ = 207.2, 159.1,
150.3, 149.2, 147.4, 134.6, 129.9 (indirect observation), 127.3, 126.1
(q, J = 3.6 Hz), 124.0 (q, J = 272.2 Hz), 117.9, 111.5, 108.7, 56.6, 56.1,
56.0, 52.3, 46.6, 42.9, 36.2, 15.2 ppm. FTIR: ν˜ = 3422, 2970, 1722,
1635, 1517, 1327, 1264, 1238, 1123, 725 cm–1. HRMS [ESI (m/z)]
calcd. for (C23H25F3N2O4 + Na)+ = 473.16586, found 473.16547 (|Δ| =
2.0 ppm). RF: 0.28 (heptane/AcOEt, 1:2). Yield: 85 %.
(2S,6R)-2-(3,4-Dimethoxyphenyl)-N-ethyl-4-oxo-6-[4-(penta-
fluoro–λ6-sulfanyl)phenyl]piperidine-1-carboxamide (5cA): Ac-
cording to the general procedure, the reaction of piperidin-4-one
2c (2.21 mg, 5.05 μmol) in tBuOH (99.9 mM) with 7A afforded urea
5cA (2.37 mg, 4.66 μmol). 1H NMR (400 MHz, CDCl3): δ = 7.81–7.71
(m, 2 H), 7.55–7.49 (m, 2 H), 6.80 (d, J = 8.2 Hz, 1 H), 6.76 (dd, J =
8.2, 2.0 Hz, 1 H), 6.48 (d, J = 2.0 Hz, 1 H), 6.25 (t, J = 5.1 Hz, 1 H),
5.07 (dd, J = 10.3, 5.0 Hz, 1 H), 4.47 (t, J = 5.2 Hz, 1 H), 3.86 (s, 3 H),
3.66 (s, 3 H), 3.24–3.09 (m, 3 H), 2.88 (dd, J = 18.5, 5.8 Hz, 1 H), 2.72
(dd, J = 17.6, 10.4 Hz, 1 H), 2.61 (dd, J = 17.6, 5.0 Hz, 1 H), 0.91 (t,
J = 7.2 Hz, 3 H) ppm. 13C NMR (101 MHz, CDCl3): δ = 206.9, 159.0,
153.1 (indirect observation), 150.4, 149.2, 147.2 (indirect observa-
tion), 134.4, 127.3, 126.7 (indirect observation), 117.9, 111.5, 108.5,
56.8, 56.1, 55.9, 51.9, 46.8, 42.7, 36.3, 15.2 ppm. FTIR: ν˜ = 3431, 2925,
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1723, 1643, 1518, 1264, 1239, 844 cm–1. HRMS [ESI (m/z)] calcd. for
(C22H25F5N2O4S + Na)+ = 531.13474, found 531.13535 (|Δ| =
0.1 ppm). RF: 0.26 (heptane/AcOEt, 1:2). Yield: 92 %.
(2S,6R)-2-(3,4-Dimethoxyphenyl)-6-(4-fluorophenyl)-N-iso-
propyl-4-oxopiperidine-1-carboxamide (5aB): According to the
general procedure, the reaction of piperidin-4-one 2a (3.50 mg,
0.01 mmol) in tBuOH (99.8 mM) with 7B afforded 5aB (3.72 mg,
8.98 μmol). 1H NMR (400 MHz, CDCl3): δ = 7.40–7.31 (m, 2 H), 7.09–
7.00 (m, 2 H), 6.80 (d, J = 8.2 Hz, 1 H), 6.75 (ddd, J = 8.2, 2.1, 0.6 Hz,
1 H), 6.67 (d, J = 2.1 Hz, 1 H), 5.95 (t, J = 5.5 Hz, 1 H), 5.23 (dd, J =
9.6, 4.9 Hz, 1 H), 4.29 (d, J = 7.2 Hz, 1 H), 3.88–3.80 (m, 1 H), 3.86 (s,
3 H), 3.74 (s, 3 H), 3.10 (dd, J = 18.2, 5.5 Hz, 1 H), 2.83 (dd, J = 17.7,
9.5 Hz, 1 H), 2.79 (dd, J = 18.2, 5.9 Hz, 1 H), 2.61 (dd, J = 17.6, 4.9 Hz,
1 H), 0.94 (d, J = 6.5 Hz, 3 H), 0.83 (d, J = 6.5 Hz, 3 H) ppm. 13C NMR
(101 MHz, CDCl3): δ = 207.8, 162.2 (d, J = 247.3 Hz), 158.4, 150.2,
149.0, 139.1 (d, J = 3.2 Hz), 135.1, 128.5 (d, J = 8.0 Hz), 117.9, 116.0
(d, J = 21.4 Hz), 111.4, 109.1, 56.1, 55.9, 52.5, 46.0, 43.7, 43.2, 23.3,
23.0 ppm. FTIR: ν˜ = 3420, 2969, 1721, 1639, 1605, 1510, 1263, 1228,
1026, 854 cm–1. HRMS [ESI (m/z)] calcd. for (C23H27FN2O4 + Na)+ =
437.18471, found 437.18465 (|Δ| = 1.4 ppm). RF: 0.41 (heptane/
AcOEt, 1:2). Yield: 84 %.
(2S,6R)-2-(3,4-Dimethoxyphenyl)-N-isopropyl-4-oxo-6-[4-(tri-
fluoromethyl)phenyl]piperidine-1-carboxamide (5bB): Accord-
ing to the general procedure, the reaction of piperidin-4-one 2b
(4.10 mg, 0.01 mmol) in tBuOH (100.2 mM) with 7B afforded 5bB
(4.48 mg, 9.65 μmol). 1H NMR (400 MHz, CDCl3): δ = 7.66–7.60 (m,
2 H), 7.57–7.51 (m, 2 H), 6.80 (d, J = 8.2 Hz, 1 H), 6.75 (ddd, J = 8.2,
2.2, 0.5 Hz, 1 H), 6.55 (d, J = 2.1 Hz, 1 H), 6.16 (t, J = 5.2 Hz, 1 H),
5.11 (dd, J = 10.2, 4.9 Hz, 1 H), 4.33 (d, J = 7.2 Hz, 1 H), 3.88–3.82
(m, 1 H), 3.86 (s, 3 H), 3.68 (s, 3 H), 3.18 (dd, J = 18.4, 4.7 Hz, 1 H),
2.87 (dd, J = 18.4, 5.7 Hz, 1 H), 2.74 (dd, J = 17.5, 10.2 Hz, 1 H), 2.61
(dd, J = 17.5, 4.9 Hz, 1 H), 0.97 (d, J = 6.5 Hz, 3 H), 0.82 (d, J = 6.5 Hz,
3 H) ppm. 13C NMR (101 MHz, CDCl3): δ = 207.2, 158.3, 150.3, 149.2,
147.5, 134.8, 129.9 (indirect observation), 127.3, 126.1 (q, J = 3.6 Hz),
122.5 (indirect observation), 117.9, 111.5, 108.7, 56.5, 56.1, 56.0,
52.3, 46.5, 43.3, 42.9, 23.3, 23.0 ppm. FTIR: ν˜ = 3417, 2968, 1722,
1642, 1516, 1326, 1262, 1238, 1123, 767 cm–1. HRMS [ESI (m/z)]
calcd. for (C24H27F3N2O4 + Na)+ = 487.18151, found 487.18134 (|Δ| =
1.5 ppm). RF: 0.41 (heptane/AcOEt, 1:2). Yield: 89 %.
(2S,6R)-2-(3,4-Dimethoxyphenyl)-N-isopropyl-4-oxo-6-[4-
(pentafluoro–λ6-sulfanyl)phenyl]piperidine-1-carboxamide
(5cB): According to the general procedure, the reaction of piper-
idin-4-one 2c (4.76 mg, 0.01 mmol) in tBuOH (99.9 mM) with 7B
afforded 5cB (5.22 mg, 9.99 μmol). 1H NMR (400 MHz, CDCl3): δ =
7.78–7.73 (m, 2 H), 7.56–7.50 (m, 2 H), 6.80 (d, J = 8.2 Hz, 1 H), 6.75
(dd, J = 8.2, 2.1 Hz, 1 H), 6.49 (d, J = 2.1 Hz, 1 H), 6.22 (t, J = 5.1 Hz,
1 H), 5.04 (dd, J = 10.4, 5.0 Hz, 1 H), 4.36 (d, J = 7.2 Hz, 1 H), 3.86
(s, 3 H), 3.66 (s, 3 H), 3.18 (dd, J = 18.4, 4.3 Hz, 1 H), 2.89 (dd, J =
18.4, 5.7 Hz, 1 H), 2.71 (dd, J = 17.5, 10.4 Hz, 1 H), 2.60 (dd, J = 17.5,
5.0 Hz, 1 H), 0.99 (d, J = 6.5 Hz, 3 H), 0.82 (d, J = 6.5 Hz, 3 H)
ppm. 13C NMR (101 MHz, CDCl3): δ = 206.9, 158.3, 152.9 (indirect
observation), 150.4, 149.3, 147.4, 134.6, 127.3, 126.8–126.6 (m),
117.9, 111.5, 108.5, 56.8, 56.2, 55.9, 51.8, 46.8, 43.3, 42.6, 23.3, 23.0
ppm. FTIR: ν˜ = 3421, 2970, 1723, 1642, 1517, 1263, 1238, 842 cm–1.
HRMS [ESI (m/z)] calcd. for (C23H27F5N2O4S + Na)+ = 545.15039,
found 545.15003 (|Δ| = 1.7 ppm). RF: 0.45 (heptane/AcOEt, 1:2).
Yield: 92 %.
Synthesis and Full Characterization of Aryl Ureas 5aC–aE, 5bC–
bE and 5cC–cE: Solution A: piperidin-4-one (2a–c, 1.0 equiv.) dis-
solved in 1,2-DCE (78.5–102.5 mM). Solution B: aryl isocyanate (7C,
7D or 7E, 1.3 equiv.) dissolved in 1,2-DCE (0.1 M). Solution A
(2.56 μL/min) was combined with B (3.32 μL/min) inside the glass
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microreactor (internal volume: 100 μL). The reaction was performed
at 80 °C for 17 min.
(2S,6R)-2-(3,4-Dimethoxyphenyl)-6-(4-fluorophenyl)-4-oxo-N-
phenylpiperidine-1-carboxamide (5aC): According to the general
procedure, the reaction of piperidin-4-one 2a (2.59 mg, 7.86 μmol)
in 1,2-DCE (88.9 mM) with 7C afforded 5aC (3.15 mg, 7.02 μmol). 1H
NMR (400 MHz, CDCl3): δ = 7.45–7.38 (m, 2 H), 7.25–7.18 (m, 2 H),
7.12–7.05 (m, 2 H), 7.05–6.98 (m, 3 H), 6.89–6.83 (m, 2 H), 6.65 (d,
J = 1.7 Hz, 1 H), 6.60 (s, 1 H), 6.19 (t, J = 5.3 Hz, 1 H), 5.35 (dd, J =
10.1, 4.9 Hz, 1 H), 3.89 (s, 3 H), 3.72 (s, 3 H), 3.21 (dd, J = 18.4, 4.9 Hz,
1 H), 2.95–2.85 (m, 2 H), 2.67 (dd, J = 17.6, 4.9 Hz, 1 H) ppm. 13C
NMR (101 MHz, CDCl3): δ = 207.2, 162.3 (d, J = 247.8 Hz), 156.6,
150.6, 149.5, 138.6, 138.5 (d, J = 3.4 Hz), 134.3, 129.1, 128.6 (d, J =
8.0 Hz), 123.7, 120.0, 118.1, 116.3 (d, J = 21.4 Hz), 111.7, 108.9, 56.6,
56.2, 56.1, 52.3, 46.3, 43.4 ppm. FTIR: ν˜ = 3388, 2924, 1722, 1662,
1510, 1265, 1235, 1026, 754 cm–1. HRMS [ESI (m/z)] calcd. for
(C26H25FN2O4 + Na)+ = 471.16906, found 471.16910 (|Δ| = 1.1 ppm).
RF: 0.24 (heptane/AcOEt, 2:1). Yield: 89 %.
(2S,6R)-2-(3,4-Dimethoxyphenyl)-4-oxo-N-phenyl-6-[4-(tri-
fluoromethyl)phenyl]piperidine-1-carboxamide (5bC): Accord-
ing to the general procedure, the reaction of piperidin-4-one 2b
(2.1 mg, 5.54 μmol) in 1,2-DCE (82.8 mM) with 7C afforded 5bC
(2.43 mg, 4.87 μmol). 1H NMR (400 MHz, CDCl3): δ = 7.69–7.64 (m,
2 H), 7.62–7.57 (m, 2 H), 7.25–7.19 (m, 2 H), 7.06–6.99 (m, 3 H), 6.89–
6.85 (m, 2 H), 6.64 (s, 1 H), 6.53–6.51 (m, 1 H), 6.41 (t, J = 5.0 Hz, 1
H), 5.22 (dd, J = 10.8, 4.8 Hz, 1 H), 3.89 (s, 3 H), 3.65 (s, 3 H), 3.29
(dd, J = 18.6, 4.1 Hz, 1 H), 2.98 (dd, J = 18.6, 5.8 Hz, 1 H), 2.80 (dd,
J = 17.5, 10.8 Hz, 1 H), 2.66 (dd, J = 17.5, 4.8 Hz, 1 H) ppm. 13C NMR
(101 MHz, CDCl3): δ = 206.6, 156.7, 150.7, 149.7, 146.7, 138.5, 133.9,
130.2 (indirect observation), 129.1, 127.4, 126.2 (q, J = 3.6 Hz), 125.9
(indirect observation), 123.9, 120.0, 118.1, 111.7, 108.6, 57.3, 56.2,
56.0, 51.9, 46.9, 42.6 ppm. FTIR: ν˜ = 3391, 2939, 1722, 1663, 1597,
1517, 1442, 1327, 1265, 1238, 755 cm–1. HRMS [ESI (m/z)] calcd. for
(C27H25F3N2O4 + Na)+ = 521.16586, found 521.16560 (|Δ | =
1.6 ppm). RF: 0.70 (heptane/AcOEt, 1:2). Yield: 88 %.
(2S,6R)-2-(3,4-Dimethoxyphenyl)-4-oxo-6-[4-(pentafluoro–λ6-
sulfanyl)phenyl]-N-phenylpiperidine-1-carboxamide (5cC): Ac-
cording to the general procedure, the reaction of piperidin-4-one
2c (2.49 mg, 5.69 μmol) in 1,2-DCE (102.5 mM) with 7C afforded 5cC
(3.22 mg, 5.79 μmol). 1H NMR (400 MHz, CDCl3): δ = 7.81–7.75 (m,
2 H), 7.61–7.55 (m, 2 H), 7.25–7.20 (m, 2 H), 7.06–7.02 (m, 3 H), 6.90–
6.86 (m, 2 H), 6.67 (s, 1 H), 6.49–6.47 (m, 1 H), 6.47–6.43 (m, 1 H),
5.16 (dd, J = 11.0, 4.9 Hz, 1 H), 3.89 (s, 3 H), 3.63 (s, 3 H), 3.28 (dd,
J = 18.7, 3.7 Hz, 1 H), 3.00 (dd, J = 18.7, 5.9 Hz, 1 H), 2.77 (dd, J =
17.5, 11.0 Hz, 1 H), 2.66 (dd, J = 17.5, 4.9 Hz, 1 H) ppm. 13C NMR
(101 MHz, CDCl3): δ = 206.3, 156.6, 153.4 (indirect observation),
150.9, 149.7, 146.9, 138.4, 133.8, 129.1, 127.4, 126.9–126.8 (m), 123.9,
120.1, 118.1, 111.7, 108.3, 57.6, 56.2, 55.9, 51.5, 47.0, 42.4 ppm. FTIR:
ν˜ = 3389, 2926, 1725, 1663, 1598, 1518, 1265, 1238, 844 cm–1. HRMS
[ESI (m/z)] calcd. for (C26H25F5N2O4S + Na)+ = 579.13474, found
579.13534 (|Δ| = 0.1 ppm). RF: 0.22 (heptane/AcOEt, 2:1). Yield:
99 %.
(2S,6R)-N-(2-Chlorophenyl)-2-(3,4-dimethoxyphenyl)-6-
(4-fluorophenyl)-4-oxopiperidine-1-carboxamide (5aD): Accord-
ing to the general procedure, the reaction of piperidin-4-one 2a
(2.4 mg, 7.28 μmol) in 1,2-DCE (90.2 mM) with 7D afforded 5aD
(2.58 mg, 5.34 μmol). 1H NMR (400 MHz, CDCl3): δ = 8.09 (dd, J =
8.2, 1.5 Hz, 1 H), 7.44–7.37 (m, 2 H), 7.25–7.17 (m, 2 H), 7.11–7.04
(m, 2 H), 7.02 (s, 1 H), 6.98–6.90 (m, 1 H), 6.85 (dd, J = 8.2, 1.9 Hz, 1
H), 6.82 (d, J = 8.2 Hz, 1 H), 6.73 (d, J = 1.9 Hz, 1 H), 6.15 (t, J =
5.6 Hz, 1 H), 5.50 (dd, J = 9.3, 5.1 Hz, 1 H), 3.86 (s, 3 H), 3.75 (s, 3
H), 3.17 (dd, J = 18.3, 5.6 Hz, 1 H), 2.94 (dd, J = 17.7, 9.3 Hz, 1 H),
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2.88 (dd, J = 18.4, 5.6 Hz, 1 H), 2.73 (dd, J = 17.7, 5.1 Hz, 1 H) ppm.
13C NMR (101 MHz, CDCl3): δ = 207.2, 162.3 (d, J = 247.7 Hz), 156.5,
150.2, 149.3, 138.0 (d, J = 3.2 Hz), 135.8, 133.7, 129.0, 128.6 (d, J =
8.1 Hz), 127.5, 124.0, 123.1, 122.3, 118.5, 116.3 (d, J = 21.5 Hz), 111.7,
109.2, 56.2, 56.1, 53.0, 46.2, 43.8 ppm. FTIR: ν˜ = 3365, 2931, 1723,
1666, 1510, 1306, 1264, 1026 cm–1. HRMS [ESI (m/z)] calcd. for
(C26H24ClFN2O4 + Na)+ = 505.13063, found 505.13076 (|Δ| =
0.3 ppm). RF: 0.35 (heptane/AcOEt, 2:1). Yield: 73 %.
(2S,6R)-N-(2-Chlorophenyl)-2-(3,4-dimethoxyphenyl)-4-oxo-6-
[4-(trifluoromethyl)phenyl]piperidine-1-carboxamide (5bD): Ac-
cording to the general procedure, the reaction of piperidin-4-one
2b (1.98 mg, 5.22 μmol) in 1,2-DCE (82.8 mM) with 7D afforded 5bD
(2.15 mg, 4.03 μmol). 1H NMR (500 MHz, CDCl3): δ = 8.09 (dd, J =
8.3, 1.5 Hz, 1 H), 7.67–7.63 (m, 2 H), 7.60–7.56 (m, 2 H), 7.25–7.19
(m, 2 H), 7.04 (s, 1 H), 6.95 (ddd, J = 8.1, 7.4, 1.5 Hz, 1 H), 6.86 (dd,
J = 8.3, 2.1 Hz, 2 H), 6.82 (d, J = 8.3 Hz, 1 H), 6.65 (d, J = 2.1 Hz, 1
H), 6.31 (t, J = 5.4 Hz, 1 H), 5.43 (dd, J = 9.7, 5.1 Hz, 1 H), 3.85 (s, 3
H), 3.70 (s, 3 H), 3.22 (dd, J = 18.5, 5.1 Hz, 1 H), 2.94 (dd, J = 18.5,
5.7 Hz, 1 H), 2.87 (dd, J = 17.6, 9.7 Hz, 1 H), 2.74 (dd, J = 17.6, 5.1 Hz,
1 H) ppm. 13C NMR (126 MHz, CDCl3): δ = 206.4, 156.4, 150.2, 149.3,
146.3, 135.6, 133.2, 130.2 (q, J = 32.7 Hz), 128.9, 127.4, 127.2, 126.1
(q, J = 3.6 Hz), 124.1, 123.7 (q, J = 272.5 Hz, indirect observation),
123.1, 122.2, 118.5, 111.7, 108.8, 56.6, 56.0, 55.9, 52.8, 46.5, 43.0
ppm. FTIR: ν˜ = 3356, 2961, 1724, 1666, 1593, 1517, 1439, 1327, 1263,
1234, 1124, 754 cm–1. HRMS [ESI (m/z)] calcd. for (C27H24ClF3N2O4
+ Na)+ = 555.12689, found 555.12901 (|Δ| = 2.8 ppm). RF: 0.33 (hept-
ane/AcOEt, 2:1). Yield: 77 %.
(2S,6R)-N-(2-Chlorophenyl)-2-(3,4-dimethoxyphenyl)-4-oxo-6-
[4-(pentafluoro–λ6-sulfanyl)phenyl]piperidine-1-carboxamide
(5cD): According to the general procedure, the reaction of piper-
idin-4-one 2c (3.4 mg, 7.77 μmol) in 1,2-DCE (78.5 mM) with 7D
afforded 5cD (4.6 mg, 7.78 μmol). 1H NMR (400 MHz, CDCl3): δ =
8.09–8.05 (m, 1 H), 7.79–7.75 (m, 2 H), 7.58–7.53 (m, 2 H), 7.24–7.20
(m, 2 H), 7.05 (s, 1 H), 6.96 (ddd, J = 8.2, 7.3, 1.5 Hz, 1 H), 6.87 (dd,
J = 8.2, 2.1 Hz, 1 H), 6.83 (d, J = 8.2 Hz, 1 H), 6.60 (d, J = 2.1 Hz, 1
H), 6.32 (t, J = 5.4 Hz, 1 H), 5.40 (dd, J = 9.7, 5.1 Hz, 1 H), 3.85 (s, 3
H), 3.68 (s, 3 H), 3.21 (dd, J = 18.6, 5.0 Hz, 1 H), 2.94 (dd, J = 18.6,
5.8 Hz, 1 H), 2.86 (dd, J = 17.6, 9.7 Hz, 1 H), 2.74 (dd, J = 17.6, 5.1 Hz,
1 H) ppm. 13C NMR (101 MHz, CDCl3): δ = 206.3, 156.4, 153.3 (indi-
rect observation), 150.4, 149.5, 146.4, 135.6, 133.2, 129.1, 127.6,
127.4, 127.0–126.8 (m), 124.3, 123.2, 122.4, 118.6, 111.8, 108.7, 56.9,
56.2, 56.0, 52.5, 46.7, 42.9 ppm. FTIR: ν˜ = 3360, 2961, 2838, 2258,
1725, 1686, 1593, 1517, 1440, 1306, 1263, 1234, 1145, 1027, 842,
751 cm–1. HRMS [ESI (m/z)] calcd. for (C26H24ClF5N2O4S + Na)+ =
613.09632, found 613.09446 (|Δ| = 3.02 ppm). Yield: 99 %.
(2S,6R)-N-(2,4-Difluorophenyl)-2-(3,4-dimethoxyphenyl)-6-(4-
fluorophenyl)-4-oxopiperidine-1-carboxamide (5aE): According
to the general procedure, the reaction of piperidin-4-one 2a
(2.30 mg, 6.98 μmol) in 1,2-DCE (87.6 mM) with 7E afforded 5aE
(3.28 mg, 6.77 μmol). 1H NMR (400 MHz, CDCl3): δ = 8.01 (td, J =
9.1, 5.9 Hz, 1 H), 7.42–7.35 (m, 2 H), 7.12–7.05 (m, 2 H), 6.86–6.77
(m, 3 H), 6.74–6.67 (m, 2 H), 6.64 (d, J = 1.8 Hz, 1 H), 6.15 (t, J =
5.4 Hz, 1 H), 5.37 (dd, J = 9.9, 4.9 Hz, 1 H), 3.87 (s, 3 H), 3.72 (s, 3
H), 3.20 (dd, J = 18.5, 5.1 Hz, 1 H), 2.91 (dd, J = 17.7, 9.9 Hz, 1 H),
2.88 (dd, J = 18.5, 5.6 Hz, 1 H), 2.68 (dd, J = 17.7, 4.9 Hz, 1 H) ppm.
13C NMR (101 MHz, CDCl3): δ = 207.0, 162.3 (d, J = 248.0 Hz), 158.2
(dd, J = 245.2, 11.4 Hz), 156.4, 152.6 (dd, J = 246.0, 12.0 Hz), 150.3,
149.4, 138.1 (d, J = 3.3 Hz), 133.6, 128.6 (d, J = 8.1 Hz), 123.5 (dd,
J = 10.4, 3.8 Hz), 122.7 (dd, J = 9.0, 2.4 Hz), 118.3, 116.3 (d, J =
21.5 Hz), 111.7, 111.1 (dd, J = 21.6, 3.7 Hz), 108.9, 103.4 (dd, J =
26.7, 23.3 Hz), 56.5, 56.10, 56.06, 52.6, 46.2, 43.4 ppm. FTIR: ν˜ =
3379, 2936, 1721, 1665, 1534, 1511, 1256, 1228, 1025, 962, 849 cm–1.
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HRMS [ESI (m/z)] calcd. for (C26H23F3N2O4 + Na)+ = 507.15021,
found 507.15113 (|Δ| = 0.7 ppm). RF: 0.29 (heptane/AcOEt, 2:1).
Yield: 97 %.
(2S,6R)-N-(2,4-Difluorophenyl)-2-(3,4-dimethoxyphenyl)-4-oxo-
6-[4-(trifluoromethyl)phenyl]piperidine-1-carboxamide (5bE):
According to the general procedure, the reaction of piperidin-4-one
2b (1.37 mg, 3.61 μmol) in 1,2-DCE (82.8 mM) with 7E afforded 5bE
(1.07 g, 2.00 μmol). 1H NMR (400 MHz, CDCl3): δ = 8.01 (td, J = 9.1,
5.9 Hz, 1 H), 7.70–7.64 (m, 2 H), 7.60–7.55 (m, 2 H), 6.88–6.79 (m, 3
H), 6.73 (s, 1 H), 6.72 (ddd, J = 11.0, 8.3, 2.8 Hz, 1 H), 6.54–6.52 (m,
1 H), 6.35 (t, J = 5.1 Hz, 1 H), 5.26 (dd, J = 10.5, 4.9 Hz, 1 H), 3.86 (s,
3 H), 3.66 (s, 3 H), 3.27 (dd, J = 18.6, 4.4 Hz, 1 H), 2.95 (dd, J = 18.6,
5.8 Hz, 1 H), 2.82 (dd, J = 17.6, 10.6 Hz, 1 H), 2.67 (dd, J = 17.6,
4.9 Hz, 1 H) ppm. 13C NMR (101 MHz, CDCl3): δ = 206.5, 156.4, 158.2
(d, J = 244.4 Hz), 152.3 (dd, J = 243.9, 11.6 Hz), 150.5, 149.6, 146.5,
133.2, 130.2 (indirect observation), 127.4, 126.2 (q, J = 3.5 Hz), 123.8
(q, J = 270.3 Hz, indirect observation), 123.4 (dd, J = 10.4, 3.9 Hz),
122.8 (dd, J = 8.8, 2.3 Hz), 118.4, 111.8, 111.2 (dd, J = 21.6, 3.8 Hz),
108.5, 103.5 (dd, J = 26.6, 23.3 Hz), 57.2, 56.1, 56.0, 52.3, 46.7, 42.7
ppm. FTIR: ν˜ = 3381, 2927, 1723, 1667, 1611, 1535, 1518, 1327, 1257,
1126, 1026 cm–1. HRMS [ESI (m/z)] calcd. for (C27H23F5N2O4 + Na)+ =
557.14702, found 557.14825 (|Δ| = 1.2 ppm). RF: 0.31 (heptane/
AcOEt, 2:1). Yield: 55 %.
(2S,6R)-N-(2,4-Difluorophenyl)-2-(3,4-dimethoxyphenyl)-4-oxo-
6-[4-(pentafluoro–λ6-sulfanyl)phenyl]piperidine-1-carboxamide
(5cE): According to the general procedure, the reaction of piperidin-
4-one 2c (1.87 mg, 4.27 μmol) in 1,2-DCE (82.9 mM) with 7E afforded
5cE (2.2 mg, 3.7 μmol). 1H NMR (400 MHz, CDCl3): δ = 8.00 (td, J =
9.1, 5.9 Hz, 1 H), 7.83–7.74 (m, 2 H), 7.60–7.52 (m, 2 H), 6.88–6.80
(m, 3 H), 6.79–6.68 (m, 2 H), 6.49 (d, J = 1.2 Hz, 1 H), 6.38 (t, J =
5.0 Hz, 1 H), 5.22 (dd, J = 10.7, 4.9 Hz, 1 H), 3.87 (s, 3 H), 3.65 (s, 3
H), 3.27 (dd, J = 18.6, 4.1 Hz, 1 H), 2.97 (dd, J = 18.6, 5.8 Hz, 1 H),
2.80 (dd, J = 17.6, 10.7 Hz, 1 H), 2.68 (dd, J = 17.6, 4.9 Hz, 1 H) ppm.
13C NMR (126 MHz, CDCl3): δ = 206.2, 158.3 (dd, J = 245.7, 11.4 Hz),
156.4, 153.5–153.1 (m), 152.7 (dd, J = 245.7, 11.5 Hz), 150.6, 149.7,
146.5, 133.1, 127.4, 127.0–126.9 (m), 123.4 (dd, J = 10.5, 3.7 Hz),
122.9 (dd, J = 9.0, 2.5 Hz), 118.4, 111.8, 111.2 (dd, J = 21.7, 3.6 Hz),
108.3, 103.5 (dd, J = 26.6, 23.3 Hz), 57.4, 56.2, 55.9, 51.9, 46.9, 42.5
ppm. FTIR: ν˜ = 3376, 2962, 1725, 1666, 1610, 1534, 1517, 1257, 843
cm–1. HRMS [ESI (m/z)] calcd. for (C26H23F7N2O4S + H)+ = 593.13395,
found 593.13686 (|Δ| = 4.0 ppm). HRMS [ESI (m/z)] calcd. for
(C26H23F7N2O4S + Na)+ = 615.11590, found 615.11657 (|Δ| =
0.2 ppm). RF: 0.25 (heptane/AcOEt, 2:1). Yield: 87 %.
Synthesis and Full Characterization of Amino Alcohols 11 and
12
(2S,4R,6R)-2-(3,4-Dimethoxyphenyl)-6-[4-(pentafluoro–λ6-
sulfanyl)phenyl]piperidin-4-ol (11): Solution A: piperidin-4-one 2c
(8.4 mg, 0.019 mmol) dissolved in THF (50.3 mM). Solution B: LiBH4
(2 M solution in THF; 1.5 equiv.) dissolved in THF (75 mM). Solution
A (13.33 μL/min) was combined with B (20 μL/min) inside the glass
microreactor (internal volume: 100 μL). The reaction was performed
at 21 °C for 3 min. 1H NMR (500 MHz, CDCl3): δ = 7.75–7.69 (m, 2
H), 7.57–7.52 (m, 2 H), 7.00 (d, J = 2.0 Hz, 1 H), 6.96 (dd, J = 8.2,
2.0 Hz, 1 H), 6.83 (d, J = 8.2 Hz, 1 H), 3.99–3.92 (m, 2 H), 3.91 (s, 3
H), 3.87 (s, 3 H), 3.81 (dd, J = 11.3, 2.4 Hz, 1 H), 2.21–2.10 (m, 2 H),
1.62–1.46 (m, 2 H) ppm. 13C NMR (126 MHz, CDCl3): δ = 153.0 (indi-
rect observation), 149.2, 148.5, 148.2, 136.7, 127.2, 126.3 (quint, J =
4.0 Hz), 118.9, 111.2, 110.1, 69.9, 59.7, 59.4, 56.09, 56.07, 43.9, 43.8
ppm. FTIR: ν˜ = 2936, 2839, 1517, 1262, 1232, 1027, 845, 815 cm–1.
HRMS [ESI (m/z)] calcd. for (C19H22F5NO3S + H)+ = 440.13188, found
440.13125 (|Δ| = 1.44 ppm). Yield: 76 %.
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(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-6-[4-(trifluoromethyl)-
phenyl]piperidin-4-ol (12): N-Selectride (3.95 mL, 3.95 mmol, 1.0 M
solution in THF) was added to a solution of piperidin-4-one 2b
(500 mg, 1.32 mmol) in dry THF (96 mL) at –78 °C. The reaction was
stirred for 1 h and it was quenched with H2O (100 mL). The solution
was allowed to reach 21 °C and then AcOEt was added. The organic
layer was separated and the aqueous layer was extracted with
AcOEt (3 × 50 mL). The combined organic layers were washed with
brine, dried with anhydrous Na2SO4, filtered off and concentrated
in vacuo. The residue was purified by SCX-2 column to afford amino
alcohol 12 (456 mg, 1.20 mmol). 1H NMR (400 MHz, CDCl3): δ =
7.66–7.53 (m, 4 H), 7.04–6.97 (m, 2 H), 6.84 (d, J = 8.1 Hz, 1 H), 4.40–
4.32 (m, 2 H), 4.25 (dd, J = 11.7, 2.7 Hz, 1 H), 3.91 (s, 3 H), 3.87 (s, 3
H), 1.95–1.87 (m, 2 H), 1.86–1.70 (m, 2 H) ppm. 13C NMR (101 MHz,
CDCl3): δ = 149.4, 149.1, 148.4, 137.5 (indirect observation), 129.4
(indirect observation), 127.3, 125.5 (q, J = 3.7 Hz), 123.0 (indirect
observation), 118.9, 111.3, 110.2, 66.2, 56.09, 56.07, 56.0, 55.7, 41.66,
41.65 ppm. FTIR: ν˜ = 2936, 1517, 1465, 1326, 1263, 1163, 1123, 1067,
1027, 806 cm–1. HRMS [ESI (m/z)] calcd. for (C20H22F3NO3 + H)+ =
382.16300, found 382.16336 (|Δ| = 0.94 ppm). Yield: 91 %.
Synthesis and Full Characterization of Alkyl Ureas 6a–c: Solution
A: compound 11 (1.0 equiv.) dissolved in tBuOH (94.3–96.5 mM).
Solution B: alkyl isocyanate (7A, 7B or 7F, 1.5 equiv.) dissolved in
tBuOH (0.1 M). Solution A (2.35 μL/min) was combined with B
(3.53 μL/min) inside the glass microreactor (internal volume:
100 μL). The reaction was performed at 50 °C for 17 min.
(2S,4R,6R)-2-(3,4-Dimethoxyphenyl)-N-ethyl-4-hydroxy-6-[4-
(pentafluoro–λ6-sulfanyl)phenyl]piperidine-1-carboxamide
(6a): According to the general procedure, the reaction of amino
alcohol 11 (2.37 mg, 5.39 μmol) in tBuOH (94.6 mM) afforded urea
6a (2.33 mg, 4.56 μmol). 1H NMR (400 MHz, CDCl3): δ = 7.74–7.70
(m, 2 H), 7.70–7.65 (m, 2 H), 6.85 (dd, J = 8.3, 2.0 Hz, 1 H), 6.81 (d,
J = 8.3 Hz, 1 H), 6.57 (d, J = 2.0 Hz, 1 H), 5.39 (t, J = 6.2 Hz, 1 H),
4.43 (t, J = 5.8 Hz, 1 H), 4.40 (dd, J = 11.7, 4.3 Hz, 1 H), 4.27–4.14
(m, 1 H), 3.86 (s, 3 H), 3.69 (s, 3 H), 2.93 (qd, J = 7.3, 5.4 Hz, 2 H),
2.43 (dt, J = 13.3, 6.2 Hz, 1 H), 2.24–2.10 (m, 2 H), 1.94 (dt, J = 13.5,
11.2 Hz, 1 H), 1.78 (d, J = 3.7 Hz, 1 H) ppm. 13C NMR (101 MHz,
CDCl3): δ = 160.7, 152.7 (indirect observation), 149.9, 148.9, 148.7
(indirect observation), 135.7, 128.1, 126.3–126.1 (m), 118.7, 111.4,
109.5, 65.8, 59.2, 56.1, 56.0, 55.3, 41.2, 37.8, 35.7, 14.8 ppm. FTIR:
ν˜ = 3414, 2937, 1627, 1517, 1263, 1140, 1027, 846, 594 cm–1. HRMS
[ESI (m/z)] calcd. for (C22H27F5N2O4S + Na)+ = 533.15094, found
533.15027 (|Δ| = 1.26 ppm). Yield: 85 %.
(2S,4R,6R)-2-(3,4-Dimethoxyphenyl)-4-hydroxy-N-isopropyl-6-
[4-(pentafluoro–λ6-sulfanyl)phenyl]piperidine-1-carboxamide
(6b): According to the general procedure, the reaction of amino
alcohol 11 (2.80 mg, 6.37 μmol) in tBuOH (94.3 mM) afforded urea
6b (2.76 mg, 5.34 μmol). 1H NMR (400 MHz, CDCl3): δ = 7.73–7.68
(m, 2 H), 7.68–7.63 (m, 2 H), 6.86 (dd, J = 8.3, 2.0 Hz, 1 H), 6.81 (d,
J = 8.2 Hz, 1 H), 6.62 (d, J = 2.1 Hz, 1 H), 5.19 (dd, J = 7.4, 5.1 Hz, 1
H), 4.36–4.28 (m, 2 H), 4.24–4.12 (m, 1 H), 3.86 (s, 3 H), 3.72 (s, 3 H),
3.60–3.50 (m, 1 H), 2.46–2.35 (m, 1 H), 2.21–2.08 (m, 2 H), 1.99–1.87
(m, 1 H), 0.75 (d, J = 6.5 Hz, 3 H), 0.61 (d, J = 6.5 Hz, 3 H) ppm. 13C
NMR (101 MHz, CDCl3): δ = 160.3, 152.7 (indirect observation),
149.8, 148.9, 148.4, 135.5, 128.2, 126.2–126.0 (m), 119.0, 111.4, 109.9,
66.2, 59.7, 56.2, 56.0, 42.4, 41.4, 38.4, 22.8, 22.5 ppm. FTIR: ν˜ = 3404,
2967, 1704, 1627, 1517, 1465, 1263, 1140, 1027, 844, 595 cm–1.
HRMS [ESI (m/z)] calcd. for (C23H29F5N2O4S + H)+ = 525.18464,
found 525.18665 (|Δ| = 3.82 ppm). Yield: 84 %.
(2S,4R,6R)-N-Benzyl-2-(3,4-dimethoxyphenyl)-4-hydroxy-6-[4-
(pentafluoro–λ6-sulfanyl)phenyl]piperidine-1-carboxamide (6c):
According to the general procedure, the reaction of amino alcohol
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11 (2.00 mg, 4.55 μmol) in tBuOH (96.5 mM) afforded urea 6c
(2.60 mg, 4.54 μmol). 1H NMR (400 MHz, CDCl3): δ = 7.76–7.66 (m,
4 H), 7.21–7.12 (m, 3 H), 6.80 (dd, J = 8.2, 2.1 Hz, 1 H), 6.77–6.72 (m,
3 H), 6.54 (d, J = 2.1 Hz, 1 H), 5.44 (t, J = 6.1 Hz, 1 H), 4.80 (t, J =
5.6 Hz, 1 H), 4.47 (dd, J = 11.5, 4.2 Hz, 1 H), 4.27–4.19 (m, 1 H), 4.17
(dd, J = 14.8, 5.8 Hz, 1 H), 4.05 (dd, J = 14.8, 5.2 Hz, 1 H), 3.85 (s, 3
H), 3.63 (s, 3 H), 2.44 (dt, J = 13.1, 6.3 Hz, 1 H), 2.24 (dt, J = 14.4,
6.5 Hz, 1 H), 2.15 (dt, J = 13.5, 5.1 Hz, 1 H), 1.97 (dt, J = 13.7, 11.1 Hz,
1 H), 1.82 (d, J = 3.3 Hz, 1 H) ppm. 13C NMR (101 MHz, CDCl3): δ =
160.5, 152.6 (indirect observation), 149.9, 148.9, 148.7, 138.4, 135.6,
128.5, 128.2, 127.3, 127.2, 126.3–126.2 (m), 118.7, 111.5, 109.4, 65.6,
59.0, 56.1, 55.9, 55.2, 45.1, 40.9, 37.6 ppm. FTIR: ν˜ = 3410, 2936,
1690, 1560, 1541, 1263, 1139, 1027, 842, 750, 595 cm–1. HRMS [ESI
(m/z)] calcd. for (C27H29F5N2O4S + Na)+ = 595.16659, found
595.16478 (|Δ| = 3.04 ppm). Yield: 99 %.
Synthesis and Full Characterization of Aryl Ureas 6d and 6e:
Solution A: compound 11 (1.0 equiv.) dissolved in 1,2-DCE (95.6–
105.0 mM). Solution B: aryl isocyanate (7C–E, 1.1 equiv.) dissolved in
1,2-DCE (0.1 M). Solution A (2.80 μL/min) was combined with B
(3.08 μL/min) inside the glass microreactor (internal volume:
100 μL). The reaction was performed at 80 °C for 17 min.
(2S,4R,6R)-2-(3,4-Dimethoxyphenyl)-4-hydroxy-6-[4-(penta-
fluoro–λ6-sulfanyl)phenyl]-N-phenylpiperidine-1-carboxamide
(6d): According to the general procedure, the reaction of amino
alcohol 11 (2.57 mg, 5.85 μmol) in 1,2-DCE (95.6 mM) afforded urea
6d (3.26 mg, 5.84 μmol). 1H NMR (400 MHz, CDCl3): δ = 7.80–7.76
(m, 2 H), 7.75–7.70 (m, 2 H), 7.20–7.14 (m, 2 H), 6.99–6.90 (m, 4 H),
6.87 (d, J = 8.2 Hz, 1 H), 6.56 (s, 1 H), 6.51 (d, J = 2.1 Hz, 1 H), 5.80
(t, J = 5.8 Hz, 1 H), 4.61 (dd, J = 12.0, 4.3 Hz, 1 H), 4.36–4.24 (m, 1
H), 3.88 (s, 3 H), 3.62 (s, 3 H), 2.58 (dt, J = 14.3, 6.9 Hz, 1 H), 2.37
(dt, J = 14.9, 5.4 Hz, 1 H), 2.18 (dt, J = 13.6, 5.1 Hz, 1 H), 2.03 (dt,
J = 13.7, 11.6 Hz, 1 H), 1.89–1.85 (m, 1 H) ppm. 13C NMR (101 MHz,
CDCl3): δ = 157.6, 152.6 (indirect observation), 150.4, 149.3, 148.9,
138.5, 135.3, 129.0, 128.2, 126.4–126.2 (m), 123.6, 119.8, 118.5, 111.6,
109.1, 65.1, 59.1, 56.2, 55.9, 53.8, 41.0, 36.6 ppm. FTIR: ν˜ = 3388,
2933, 2841, 1686, 1647, 1501, 1443, 1420, 1264, 1237, 1140, 1027,
843, 754 cm–1. HRMS [ESI (m/z)] calcd. for (C26H27F5N2O4S + Na)+ =
581.15094, found 581.14995 (|Δ| = 1.70 ppm). Yield: 99 %.
(2S,4R,6R)-N-(2-Chlorophenyl)-2-(3,4-dimethoxyphenyl)-4-
hydroxy-6-[4-(pentafluoro–λ6-sulfanyl)phenyl]piperidine-1-
carboxamide (6e): According to the general procedure, the reac-
tion of amino alcohol 11 (3.40 mg, 7.74 μmol) in 1,2-DCE (105.0 mM)
afforded urea 6e (3.81 mg, 6.42 μmol). 1H NMR (400 MHz, CDCl3):
δ = 8.01 (dd, J = 8.6, 1.6 Hz, 1 H), 7.79–7.75 (m, 2 H), 7.75–7.70 (m,
2 H), 7.21–7.14 (m, 2 H), 6.97 (s, 1 H), 6.95–6.87 (m, 2 H), 6.82 (d, J =
8.3 Hz, 1 H), 6.61 (d, J = 2.2 Hz, 1 H), 5.83 (t, J = 6.0 Hz, 1 H), 4.85
(dd, J = 11.1, 4.8 Hz, 1 H), 4.39–4.37 (m, 1 H), 3.84 (s, 3 H), 3.65 (s,
3 H), 2.57 (dt, J = 14.4, 7.0 Hz, 1 H), 2.36 (dt, J = 14.9, 5.8 Hz, 1 H),
2.26 (dt, J = 13.9, 5.4 Hz, 1 H), 2.09 (dt, J = 13.9, 10.5 Hz, 1 H), 1.87
(d, J = 3.6 Hz, 1 H) ppm. 13C NMR (101 MHz, CDCl3): δ = 157.1, 152.6
(indirect observation), 150.1, 149.1, 148.5, 135.8, 134.8, 129.0, 128.2,
127.5, 126.5–126.3 (m), 123.9, 123.0, 122.0, 119.0, 111.8, 109.2, 64.9,
58.3, 56.2, 56.0, 54.0, 40.8, 36.6 ppm. FTIR: ν˜ = 3362, 2936, 2838,
2258, 1735, 1663, 1517, 1439, 1263, 1140, 1027, 843, 754 cm–1.
HRMS [ESI (m/z)] calcd. for (C26H26ClF5N2O4S + H)+ = 593.13002,
found 593.12885 (|Δ| = 1.98 ppm). Yield: 83 %.
Synthesis and Full Characterization of Ureas 13a and 13b
(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-4-hydroxy-N-isopropyl-6-
[4-(trifluoromethyl)phenyl]piperidine-1-carboxamide 13a and
13b: Isopropyl isocyanate (7B; 0.01 mL, 0.12 mmol) was added to
a solution of piperidin-4-ol 12 (46.2 mg, 0.12 mmol) in CH2Cl2
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(1.2 mL) at 21 °C and the reaction was stirred for 20 h. The solvent
was removed under vacuo and the crude was purified by column
chromatography (CH2Cl2 → CH2Cl2/MeOH, 10:1) to afford com-
pounds 13a and 13b (21.5 mg, 0.046 mmol). Combined yield:
38 %.
13a: 1H NMR (400 MHz, CDCl3): δ = 7.59–7.49 (m, 4 H), 6.84–6.74
(m, 2 H), 6.64 (br. s, 1 H), 5.65 (t, J = 5.4 Hz, 1 H), 4.90 (dd, J = 10.0,
4.1 Hz, 1 H), 4.43 (quint, J = 5.2 Hz, 1 H), 4.33 (d, J = 7.4 Hz, 1 H),
3.83 (s, 3 H), 3.82–3.71 (m, 1 H), 3.71 (s, 3 H), 2.76–2.64 (m, 1 H),
2.15–2.07 (m, 1 H), 2.00 (dt, J = 15.0, 5.4 Hz, 1 H), 1.84 (dt, J = 14.9,
3.8 Hz, 1 H), 0.89 (d, J = 6.5 Hz, 3 H), 0.74 (d, J = 6.4 Hz, 3 H) ppm.
13C NMR (101 MHz, CDCl3): δ = 159.3, 149.7, 148.65–148.59 (m),
148.5, 136.1, 129.2 (q, J = 32.6 Hz), 127.4, 125.5 (q, J = 3.7 Hz), 122.8
(indirect observation), 118.3, 111.3, 109.6, 62.4, 56.0, 55.9, 54.1, 52.1,
42.8, 39.6, 36.1, 23.2, 22.9 ppm. FTIR: ν˜ = 3415, 2965, 2937, 1619,
1517, 1465, 1327, 1262, 1164, 1123, 1070, 1019, 808 cm–1. HRMS
[ESI (m/z)] calcd. for (C24H29F3N2O4 + Na)+ = 489.19771, found
489.19701 (|Δ| = 1.43 ppm).
13b: 1H NMR (400 MHz, CDCl3): δ = 7.69–7.62 (m, 2 H), 7.61–7.54
(m, 2 H), 6.90–6.84 (m, 1 H), 6.81 (dd, J = 8.2, 0.8 Hz, 1 H), 6.67 (d,
J = 1.9 Hz, 1 H), 5.12 (dd, J = 7.3, 5.2 Hz, 1 H), 4.36 (dd, J = 11.7,
3.9 Hz, 1 H), 4.32 (d, J = 7.5 Hz, 1 H), 4.23–4.11 (m, 1 H), 3.86 (s, 3
H), 3.73 (s, 3 H), 3.60–347 (m, 1 H), 2.41–2.33 (m, 1 H), 2.20–2.10 (m,
2 H), 2.01–1.91 (m, 1 H), 0.72 (d, J = 5.9 Hz, 3 H), 0.61 (d, J = 6.6 Hz,
3 H) ppm. 13C NMR (101 MHz, CDCl3): δ = 160.4, 149.7, 148.8, 148.4,
135.6, 129.4 (indirect observation), 128.2, 125.4, 122.9 (indirect ob-
servation), 119.1, 111.3, 110.0, 66.3, 59.6, 56.7, 56.1, 56.0, 42.4, 41.2,
38.7, 22.8, 22.5 ppm. FTIR: ν˜ = 3414, 2930, 1620, 1517, 1465, 1325,
1263, 1164, 1122, 1027, 842 cm–1. HRMS [ESI (m/z)] calcd. for
(C24H29F3N2O4 + Na)+ = 489.19771, found 489.19688 (|Δ| =
1.70 ppm).
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